Waters Co. (NYSE:WAT) SVP David Terricciano sold 21,997 shares of the company’s stock in a transaction that occurred on Friday, December 15th. The shares were sold at an average price of $197.52, for a total value of $4,344,847.44. Following the sale, the senior vice president now owns 9,173 shares in the company, valued at approximately $1,811,850.96. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Shares of Waters Co. (NYSE:WAT) traded up $2.58 during trading on Monday, hitting $196.56. The stock had a trading volume of 1,123,300 shares, compared to its average volume of 515,783. The company has a debt-to-equity ratio of 0.66, a current ratio of 6.16 and a quick ratio of 5.71. The firm has a market cap of $15,633.01, a PE ratio of 27.30, a price-to-earnings-growth ratio of 2.85 and a beta of 0.82. Waters Co. has a fifty-two week low of $133.71 and a fifty-two week high of $201.95.

Waters (NYSE:WAT) last posted its earnings results on Tuesday, October 24th. The medical instruments supplier reported $1.77 EPS for the quarter, beating the consensus estimate of $1.74 by $0.03. Waters had a return on equity of 21.21% and a net margin of 24.06%. The firm had revenue of $565.58 million for the quarter, compared to analysts’ expectations of $555.25 million. During the same period last year, the firm earned $1.57 EPS. The firm’s revenue was up 7.4% compared to the same quarter last year. research analysts forecast that Waters Co. will post 7.42 EPS for the current year.

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Parametric Portfolio Associates LLC increased its position in Waters by 6.4% in the 3rd quarter. Parametric Portfolio Associates LLC now owns 166,698 shares of the medical instruments supplier’s stock valued at $29,926,000 after acquiring an additional 10,015 shares during the period. IFM Investors Pty Ltd acquired a new stake in Waters in the 3rd quarter valued at approximately $398,000. Bares Capital Management Inc. increased its position in Waters by 0.6% in the 3rd quarter. Bares Capital Management Inc. now owns 728,948 shares of the medical instruments supplier’s stock valued at $130,861,000 after acquiring an additional 4,663 shares during the period. California Public Employees Retirement System increased its position in Waters by 6.6% in the 3rd quarter. California Public Employees Retirement System now owns 207,968 shares of the medical instruments supplier’s stock valued at $37,334,000 after acquiring an additional 12,868 shares during the period. Finally, Janney Montgomery Scott LLC acquired a new stake in Waters in the 3rd quarter valued at approximately $459,000. Hedge funds and other institutional investors own 92.29% of the company’s stock.

A number of brokerages have recently weighed in on WAT. Morgan Stanley upgraded Waters from an “underweight” rating to an “equal weight” rating and set a $192.00 price target on the stock in a research report on Monday, December 4th. Bank of America increased their price target on Waters from $192.00 to $202.00 and gave the stock a “neutral” rating in a research report on Friday, November 10th. Cowen reiterated a “hold” rating and set a $190.00 price target on shares of Waters in a research report on Friday, November 3rd. Zacks Investment Research cut Waters from a “buy” rating to a “hold” rating in a research report on Thursday, October 26th. Finally, Citigroup reiterated a “neutral” rating and set a $180.00 price target on shares of Waters in a research report on Wednesday, October 25th. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus target price of $193.62.

COPYRIGHT VIOLATION WARNING: This article was first reported by American Banking News and is the property of of American Banking News. If you are accessing this article on another domain, it was illegally copied and reposted in violation of U.S. & international copyright & trademark law. The legal version of this article can be viewed at https://www.americanbankingnews.com/2017/12/18/waters-co-wat-svp-david-terricciano-sells-21997-shares.html.

Waters Company Profile

Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.

Insider Buying and Selling by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.